Joshua Bornhorst, Ph.D., explains how Mayo Clinic Laboratories' unique blood test identifies pregnant women at risk of developing preeclampsia with severe features. Test results can guide clinical management, to safeguard maternal and neonatal health.

Speaker 3: (00:32)
Can you share a little about yourself and your background?

Speaker 3: (01:00)
Can you provide us with an overview of this new preeclampsia assay?

Speaker 3: (02:33)
Can you share what will be reported with this assay?

Speaker 3: (03:07)
Which patients should have this testing and at what point should it be performed?

Speaker 3: (03:35)
Can you share what alternative test options are available today for preeclampsia?

Speaker 3: (03:52)
How are the test results used in patient care?